LLOYD STOKES: Open Payments
NPI 1457546319 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 46 payments from 12 companies in 2025. Trend: 2023 $874 · 2024 $448 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $249 |
| Novo Nordisk Inc | 14 | $218 |
| SANOFI-AVENTIS U.S. LLC | 3 | $69 |
| Astellas Pharma US Inc | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| PFIZER INC. | 1 | $25 |
| Cipher Pharmaceuticals US LLC | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: Wegovy, VRAYLAR, TZIELD, QULIPTA, UBRELVY, Rybelsus, Veozah, CAPLYTA.
Industry payments across AL — which companies pay providers there.
